Beyond Conventional PDOs: Organoids for Tumorigenesis for Gut Cancer Modeling and Fast Clinical Decision
Insight is provided into the potential use of tumorigenesis models and their key metrics, drawing on advances in gut medicine, which hold promise for future early diagnosis and clinical decision‐making.